论文部分内容阅读
目的 探讨急性心肌梗死 (AMI)尿激酶溶栓组和非溶栓组患者预后和QT离散度 (QTd)的变化。方法 比较溶栓组 ( 94例 )和非溶栓组 ( 3 2例 )患者心脏事件、左室功能、室性心律失常和QTd的改变。结果 心脏事件的发生率溶栓组低于非溶栓组 ,左室功能溶栓组和非溶栓组分别为 ( 5 1 8± 7 2 ) %及 ( 3 6 8± 7 0 ) % ,室性心律失常分别为 ( 15± 6) %及 ( 2 6± 10 ) % ,d 2QTd分别为 ( 4 2 78± 14 84)ms及 ( 5 6 84± 19 18)ms。结论 溶栓治疗AMI是安全的 ,能改善患者的预后。
Objective To investigate the changes of prognosis and QT dispersion (QTd) in patients with acute myocardial infarction (AMI) treated with urokinase and non-thrombolytic therapy. Methods The changes of cardiac events, left ventricular function, ventricular arrhythmia and QTd were compared between thrombolysis group (94 cases) and non thrombolysis group (32 cases). Results The incidence of cardiac events was lower in the thrombolytic group than in the non-thrombolytic group (51.87%) and (36.87%) in the non-thrombolytic group The arrhythmia was (15 ± 6)% and (26 ± 10)% respectively, and the d 2QTd was (4278 ± 1484) ms and (5684 ± 1918) ms, respectively. Conclusion Thrombolytic therapy of AMI is safe and can improve the prognosis of patients.